The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,047,459 in first-year total cost, median $794,261.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BST-J (70)]9
Most frequent institutions
- BUCK INSTITUTE FOR RESEARCH ON AGING1
- CALIFORNIA INSTITUTE OF TECHNOLOGY1
- RUSH UNIVERSITY MEDICAL CENTER1
- STANFORD UNIVERSITY1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | A Global Map of Interactions Among Human Cell Surface Proteins and Secreted Ligands1R01GM150125-01 | GARCIA, KENAN CHRISTOPHERTHOMSON, MATTHEW W.ZINN, KAI G | CALIFORNIA INSTITUTE OF TECHNOLOGY, CA | $1,717,895 | ZRG1 |
| 2022 | Primary Cilia: A Novel Signaling Gateway To Neural Circuit Modulation1R01MH132710-01 | ANTON, EVA SLICHTMAN, JEFF WYASUDA, RYOHEI | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,126,098 | ZRG1 |
| 2022 | Leveraging Noninvasive Transcutaneous Vagus Nerve Stimulation and Smartphone Technology to Reduce Suicidal Behaviors and Suicide Among Highly Vulnerable Adolescents1R01MH133226-01 | BEAUCHAINE, THEODORE PATRICKSHEFTALL, ARIELLE HOPEVALENTINO, KRISTIN | UNIVERSITY OF NOTRE DAME, IN | $1,014,872 | ZRG1 |
| 2022 | Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery1R01NS131409-01 | GOODARZI, HANIICHIDA, JUSTIN KAWIKA | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $1,007,803 | ZRG1 |
| 2022 | Building the foundations of commensal vaccines1R01AI175642-01 | FISCHBACH, MICHAEL ANDREW | STANFORD UNIVERSITY, CA | $794,261 | ZRG1 |
| 2022 | Transforming adolescent mental health through accessible, scalable, technology-supported small-group instruction1R01MH133225-01 | VAN RYZIN, MARK J | UNIVERSITY OF OREGON, OR | $756,777 | ZRG1 |
| 2022 | Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer1R01CA279487-01 | BISHEHSARI, FARAZ | RUSH UNIVERSITY MEDICAL CENTER, IL | $663,143 | ZRG1 |
| 2022 | A smart cell drug (SmaCD) delivery platform for mobile, targetable, and self-regulated combination therapy: a model project to rescue antibodies from Alzheimer's disease (AD) clinical trial failures1R01AG081989-01 | ANDERSEN, JULIE KAY | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | $534,821 | ZRG1 |
| 2022 | Unlocking the Chemical Space of Cancer-Associated Perturbations1R01CA280833-01 | BRADY, DONITA CBURSLEM, GEORGEBUSINO, LUCAGADE, TERENCE PWITZE, ERIC S. | UNIVERSITY OF PENNSYLVANIA, PA | $431,789 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.